View More Recent Stories
-
Ligand Pharma (LGND) Verona Pharma Announces FDA Approval of Ohtuvayre, First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
-
Verona Pharma (VRNA) PT Raised to $36 at H.C. Wainwright
-
Verona Pharma plc (VRNA) Announces US FDA Approval of Ohtuvayre
